Palatin and US Army work on inhaled anthrax test:
This article was originally published in Clinica
Palatin Technologies has teamed-up with the US Army to evaluate the firm's radiolabelled imaging agent, LeuTech, for early detection of inhaled anthrax infection. A study enrolling up to 500 individuals at potential risk of inhaling anthrax spores was to begin last week at the Walter Reed Army Medical Center, Washington. LeuTech is a monoclonal antibody that binds to white bloods cells, which collect at infection sites, enabling the infection to be detected easily and rapidly using a gamma camera (see this issue, p 9).